SLDB
Price
$7.06
Change
-$0.21 (-2.89%)
Updated
Sep 27 closing price
UNCY
Price
$0.42
Change
+$0.01 (+2.44%)
Updated
Sep 27 closing price
44 days until earnings call
Ad is loading...

SLDB vs UNCY

Header iconSLDB vs UNCY Comparison
Open Charts SLDB vs UNCYBanner chart's image
Solid Biosciences
Price$7.06
Change-$0.21 (-2.89%)
Volume$185.28K
CapitalizationN/A
Unicycive Therapeutics
Price$0.42
Change+$0.01 (+2.44%)
Volume$989.06K
CapitalizationN/A
View a ticker or compare two or three
SLDB vs UNCY Comparison Chart
Loading...
SLDB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
SLDB vs. UNCY commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLDB is a Hold and UNCY is a StrongBuy.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (SLDB: $8.47 vs. UNCY: $0.32)
Brand notoriety: SLDB and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLDB: 49% vs. UNCY: 133%
Market capitalization -- SLDB: $272.48M vs. UNCY: $39.33M
SLDB [@Biotechnology] is valued at $272.48M. UNCY’s [@Biotechnology] market capitalization is $39.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.37B to $0. The average market capitalization across the [@Biotechnology] industry is $3.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLDB’s FA Score shows that 2 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • SLDB’s FA Score: 2 green, 3 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, SLDB is a better buy in the long-term than UNCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLDB’s TA Score shows that 5 TA indicator(s) are bullish while UNCY’s TA Score has 5 bullish TA indicator(s).

  • SLDB’s TA Score: 5 bullish, 3 bearish.
  • UNCY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both SLDB and UNCY are a good buy in the short-term.

Price Growth

SLDB (@Biotechnology) experienced а -7.43% price change this week, while UNCY (@Biotechnology) price change was -10.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.80%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was -8.06%.

Reported Earning Dates

SLDB is expected to report earnings on May 11, 2023.

UNCY is expected to report earnings on Nov 12, 2024.

Industries' Descriptions

@Biotechnology (+3.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLDB($272M) has a higher market cap than UNCY($39.3M). SLDB YTD gains are higher at: 37.948 vs. UNCY (-63.363).
SLDBUNCYSLDB / UNCY
Capitalization272M39.3M692%
EBITDAN/AN/A-
Gain YTD37.948-63.363-60%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash32.2MN/A-
Total Debt25.8MN/A-
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLDBUNCY
RSI
ODDS (%)
N/A
Bullish Trend about 1 month ago
0%
Stochastic
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
MACD
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 2 months ago
0%
Bullish Trend about 1 month ago
0%
Declines
ODDS (%)
Bearish Trend about 2 months ago
90%
Bearish Trend about 2 months ago
90%
BollingerBands
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Aroon
ODDS (%)
N/A
Bearish Trend about 1 month ago
0%
View a ticker or compare two or three
Ad is loading...
SLDB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with ACLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-5.15%
ACLX - SLDB
42%
Loosely correlated
-3.81%
BBIO - SLDB
38%
Loosely correlated
+3.20%
VRDN - SLDB
36%
Loosely correlated
-1.43%
FULC - SLDB
35%
Loosely correlated
-5.26%
VCEL - SLDB
35%
Loosely correlated
-5.05%
More

UNCY and

Correlation & Price change

A.I.dvisor tells us that UNCY and SLDB have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UNCY and SLDB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
-5.89%
SLDB - UNCY
28%
Poorly correlated
-5.15%
BNOX - UNCY
24%
Poorly correlated
-2.40%
NKTR - UNCY
24%
Poorly correlated
-3.12%
SYRS - UNCY
23%
Poorly correlated
-5.49%
DRTS - UNCY
23%
Poorly correlated
-4.49%
More